APONTIS PHARMA AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.92 EUR | +0.51% |
|
+1.80% | +69.23% |
| 04-05 | Apontis Bags Distribution Deal with Novartis Unit for Two Asthma Medications | MT |
| 03-28 | Apontis Pharma AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Evolution of the average Target Price on Apontis Pharma AG
Price target over the last 5 years
History of analyst recommendation changes
4b57ec3cd03036.jbWy7VTnjRMAy7p7L609-nWeAKUbpuqY4khDFzzLnTM.xdDqmTvU2nZpjvAiSOVlqhDXTuho9LvNtQkJJkiTqH3P0Oq_OID3Qne98w~0be1e2de20d5c2231bc2c9e3535b8c20
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
8.26
EUR
Average target price
17.5
EUR
Spread / Average Target
+111.86%
High Price Target
20
EUR
Spread / Highest target
+142.13%
Low Price Target
16
EUR
Spread / Lowest Target
+93.70%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- APPH Stock
- APPH Stock
- Consensus Apontis Pharma AG
